• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Life Sciences | News, Analysis, Insights - HIT Consultant

Wolters Kluwer, SAS Integrate to Power Real-World Evidence (RWE) Analytics

by Jasmine Pennic 03/03/2020 Leave a Comment

Wolters Kluwer, SAS Integrate to Power Real-World Evidence (RWE) Analytics

- SAS to leverage Wolters Kluwer’s Health Language portfolio of data quality solutions to power real-world evidence (RWE) analytics within SAS Health. - Through a disease-centric approach, Health Language will enable SAS Health’s clients to more effectively manage reference data, such as ICD-10, CPT® and SNOMED CT, establish relationships between clinical and claims data and extract value from unstructured text within the medical record–providing a comprehensive view of a patient’s clinical
Read More

IBM Watson Health Launches Data-Driven Tool to Optimize Clinical Trials

by Fred Pennic 02/18/2020 Leave a Comment

IBM Watson Health Launches Data-Driven Tool to Optimize Clinical Trials

- Today, IBM announced its data-driven tool, IBM Study Advance that optimizes clinical trial protocol design by providing access to real-world patient population data, a collaborative workplace and standardizing protocol template guidance. - IBM Study Advance’s collaborative workspace is designed to allow near real-time collaboration with study design team members who can manage and assign the team to specific sections of the protocol.  IBM Watson Health today unveiled its newest
Read More

LexaGene Launches Genetic Analyzer for Detection of Pathogens like Coronavirus

by Fred Pennic 02/07/2020 Leave a Comment

LexaGene Launches Genetic Analyzer for Detection of Pathogens like Coronavirus

- LexaGene has created a genetic analyzer that can identify specific bacteria and viruses as well as any antibiotic/antimicrobial resistance that they have, within just one hour. - The device does this completely automatically, without the need for trained lab technicians, by amplifying the genetic material in the sample to identify it, rather than waiting for a culture which can take several days.  LexaGene Holdings, Inc., a biotechnology company that develops genetic analyzers
Read More

Verana Health Acquires PYAA Analytics; Raises $100M to Expand Real World Data Insights

by Fred Pennic 02/05/2020 Leave a Comment

Verana Health Acquires PYAA Analytics; Raises $100M to Expand Real World Data Insights

- Verana Health, a health tech company (in the real-world evidence and clinical trials space) is announcing a $100M funding round today — led by GV (with participation by Bain, Define, Brook Byers and others). - Additionally, they acquired Knoxville-based PYAA analytics, a company spun out of Oak Ridge National Laboratory to leverage the PYAA team’s capabilities to integrate imaging, genomic, and claims data sources into the existing data platform and link these data with the EHR data
Read More

Notable Launches Observational Clinical Trial for Patients with Blood Cancer

by Fred Pennic 01/23/2020 Leave a Comment

Notable Launches Observational Clinical Trial for Patients with Blood Cancer

 - Notable launches The ANSWer Study, it's new observational clinical trial for patients with blood cancer and is currently enrolling patients.- The primary assessment is to establish a tumor registry with annotated clinical outcomes.Notable, a San Francisco, CA-based company redefining cancer treatment with a clinically validated platform that rapidly advances drug development, is currently enrolling patients in its new observational clinical trial. The clinical trial will take place at
Read More

CVS: 4 Approaches to Reduce The Cost Impact of Gene Therapies

by Jasmine Pennic 01/15/2020 Leave a Comment

- While the life-changing and life-saving potential of gene therapies is tremendously exciting, finding ways to pay for these treatments is a significant challenge for families and payors.- With prices for a single treatment as high as $2 million, many employers are struggling to find ways to offer coverage without bankrupting their health plans, or even their companies.- Newly released CVS Health white paper outlines four key approaches that health plans and employers can utilize to reduce the
Read More

Duke, Deerfield Management Form Four Points Innovation to Invest Up $130M in Drug Discovery

by Fred Pennic 01/06/2020 Leave a Comment

Duke, Deerfield Management Form Four Points Innovation to Invest Up $130M in Drug Discovery

- Duke University and Deerfield Management Company form major translation research collaboration company, Four Points Innovation. - Deerfield will invest up to $130 million of initial funding to accelerate drug discovery at Duke for 10 years. Duke University and Deerfield Management Company, a healthcare investment firm has announced the creation of a major translational research collaboration company, Four Points Innovation. Spearheaded by Duke University’s Office of Licensing &
Read More

Alphabet’s Verily, Emory Healthcare Partner to Leverage Big Data to Optimize Medication & Lab Ordering Patterns

by Fred Pennic 12/26/2019 Leave a Comment

Alphabet’s Verily, Emory Healthcare Partner to Leverage Big Data to Optimize Medication & Lab Ordering Patterns

- Alphabet’s Verily is partnering with Atlanta, GA-based Emory Healthcare on deep analysis of medications and lab ordering patterns for improved diagnosis and treatment at the point of care. - Verily is a subsidiary of Alphabet focused on life sciences and healthcare that develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage diseaseVerily, an Alphabet company is partnering with Emory Healthcare to deploy new solutions to help
Read More

Verantos Awarded NIH Grant to Fund Clinical Phenotyping in Real-World Evidence

by Fred Pennic 12/10/2019 Leave a Comment

Verantos Awarded NIH Grant to Fund Clinical Phenotyping in Real-World Evidence

- Verantos has been awarded a grant from the National Institutes of Health (NIH) to fund advanced clinical phenotyping in real-world evidence (RWE) studies.- Grant number R44TR002437 ties directly to the 21st Century Cures Act's national goals of increasing the use of RWE to refine the standard of care and create a more tailored approach to therapy.Verantos, a Palo Alto, CA-based provider of regulatory-grade real-world evidence (RWE) studies, today announced that it has received a grant from the
Read More

Cleveland Clinic Awarded $12M to Study Link Between Gut Microbes & Heart Disease

by Jasmine Pennic 11/22/2019 Leave a Comment

Cleveland Clinic Awarded $12M to Study Gut Microbes and Heart Disease

- Stanley Hazen, M.D., Ph.D., director of Cleveland Clinic's Center for Microbiome & Human Health and his team has been awarded a $12M NIH grant to study the link between gut microbes, heart disease. - The new research program will consist of three specialized projects and four supporting cores focused on the gut microbiome. TheNational Institutes of Health (NIH) has awarded more than $12 million to Cleveland Clinic researchers to study the critical link between gut microbial pathways and
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 86
  • Go to page 87
  • Go to page 88
  • Go to page 89
  • Go to page 90
  • Interim pages omitted …
  • Go to page 92
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

HLTH 2025 Coverage

HLTH 2025 Day 1 Summary & Insights: AMA Launches AI Governance Center, Google Cloud, Microsoft, ChatGPT for Medicine

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Northwell Health Selects to Deploy Abridge’s Ambient AI Across 28 Hospitals

Northwell Health to Deploy Abridge’s Ambient AI Across 28 Hospitals

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |